Gudoityte G

Functional profiling of ovarian cancer models reveals Bcl-xL/NOTCH targeting to overcome resistance

Gudoityte G, Berkovska O, Orre LM, ..., Joneborg U, Seashore-Ludlow B

NPJ Precis Oncol 10 (1) - [2026-08-04; online 2026-08-04]

NGI Short read [Service] NGI Stockholm (Genomics Production) [Service] National Genomics Infrastructure [Service]

Systematic profiling of cancer-fibroblast interactions reveals drug combinations in ovarian cancer.

Gudoityte G, Sharma O, Leuenberger L, ..., Kallioniemi O, Seashore-Ludlow B

Mol Oncol 19 (9) 2574-2593 [2025-09-00; online 2025-05-24]

Affinity Proteomics Stockholm [Service] Clinical Genomics [Service] Clinical Genomics Stockholm [Service]

Ex Vivo Drug Sensitivity of Pleural Effusion-Derived Cells from Lung Cancer and Pleural Mesothelioma Patients Is Linked to Clinical Response.

Hutyra-Gram Ötvös R, Krynska H, Gudoityte G, ..., Seashore-Ludlow B, Dobra K

Cancers (Basel) 17 (14) - [2025-07-16; online 2025-07-16]

Clinical Genomics [Service] Clinical Genomics Stockholm [Service]